Tubulin as a target for anticancer drugs: Agents which interact with the mitotic spindle

Allan Jordan, John A. Hadfield, Nicholas J. Lawrence, Alan T McGown

Research output: Contribution to journalArticlepeer-review

Abstract

Tubulin is the biochemical target for several clinically used anticancer drugs, including paclitaxel and the vinca alkaloids vincristine and vinblastine. This review describes both the natural and synthetic agents which are known to interact with tubulin. Syntheses of the more complex agents are referenced and the potential clinical use of the compounds is discussed. This review describes the biochemistry of tubulin, microtubules, and the mitotic spindle. The agents are discussed in relation to the type of binding site on the protein with which they interact. These are the colchicine, vinca alkaloid, rhizoxin/maytansine, and tubulin sulfhydryl binding sites. Also included are the agents which either bind at other sites or unknown sites on tubulin. The literature is reviewed up to October 1997.

Original languageEnglish
Pages (from-to)259-296
Number of pages38
JournalMedicinal Research Reviews|Med Res Rev
Volume18
Issue number4
DOIs
Publication statusPublished - 1998

Keywords

  • Antimitotic
  • Binding site
  • Cancer
  • Tubulin

Fingerprint

Dive into the research topics of 'Tubulin as a target for anticancer drugs: Agents which interact with the mitotic spindle'. Together they form a unique fingerprint.

Cite this